FDA clears new EndoFLIP catheter
This article was originally published in Clinica
Executive Summary
The US FDA has granted 510(k) clearance for a new EndoFLIP catheter, developed by Crospon, to measure sleeves created during bariatric surgery. The minimally-invasive procedure to treat obesity involves removing part of the stomach, leaving the remaining part in the shape of a tube or sleeve. The EndoFLIP EF620 sleeve catheter can ensure that this sleeve is not too small, thereby reducing the risk of leaks. EndoFLIP originally received 510(k) clearance in December 2009 to allow bariatric surgeons to measure and set gastric band stoma size during surgery (www.clinica.co.uk, 12 January 2010). Galway, Ireland-based Crospon CE marked EndoFLIP for sale in Europe in January 2009, which covered its use in the measurement of sleeves.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.